Form 4 for ANIX Anixa Biosciences Inc
Accepted 2022-01-13 00:00:00 ET · period of report 2022-01-12 · accession 0001493152-22-001112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-13 | 2022-01-12 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.28 | +5,000 | 978.1K | +0.5% | +$16.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-12 | P | A | 5,000 | $3.28 | 978,070 | D | — | — |